Ferric carboxymaltose is a parenteral iron preparation with characteristics that allow larger single doses to be administered over a shorter infusion period compared with existing IV iron preparations. Ferric carboxymaltose, a novel iron complex that consists of a ferric hydroxide core stabilized by a carbohydrate shell, allows for controlled delivery of iron to target tissues
Ferric Carboxymaltose is a high-molecular-weight iron-carbohydrate complex synthesized via controlled oxidation of ferric hydroxide. It serves as an intravenous iron replacement therapy with the CAS number 25644-52-8.
Strictly contraindicated for patients with known hypersensitivity to iron compounds. Monitor serum ferritin and transferrin saturation to avoid iron overload. Store in original packaging at controlled room temperature, protected from light.
(All Rights Reserved) (All Rights Reserved)
